A bacterium‐attenuated S. typhimurium (VNP) system is developed to deliver GSDMD into murine 4T1 tumor cells to initiate GSDMD‐triggered pyroptosis for immunotherapy. The gene discussed is GSDMD; the disease is neoplasm.